Idiopathic thrombocytopenic purpura in adults: Current issues for pathogenesis, diagnosis and management

Hematology Journal

Volumn 5, Issue SUPPL. 3, 2004, Pages

  George, James N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN; PREDNISONE; QUININE; RITUXIMAB; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; ASPERGILLOSIS; BLOOD SMEAR; BONE MARROW BIOPSY; CELL DESTRUCTION; CLINICAL OBSERVATION; CONSERVATIVE TREATMENT; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG MEGADOSE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MYCOSIS; PATHOGENESIS; PATIENT CARE; PHYSICAL EXAMINATION; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADULT; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 4043081983     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200414     Document Type: Article

References (20)

1. McMillan R, Wang L,, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-1369.
2. Sashida G, Ohyashiki JH, Ito Y, Ohyashiki K. Monoclonal constitution of neutrophils detected by PCR-based human androgen receptor gene assay in a subset of idiopathic thrombocytopenic purpura patients. Leuk Res 2002; 26: 825-830.
3. George JN. Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk Res 2002; 26: 789-790.
4. Frederiksen H, Schmidt K. The incidence of ITP in adults increases with age. Blood 1999; 94: 909-913.
5. Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549-2554.
6. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PRA. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122: 966-974.
7. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al. Idiopathic thromboctyopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
8. British Committee for Standards in Haematology Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596.
9. Leach JW, Hussein KK, George JN. Acquired pure megakaryocytic aplasia: Report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol 1999; 62: 115-117.
10. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Int Med 1998; 129: 886-890.
11. Azuno Y, Yaga K, Sasayama T, Kimoto K. Thrombocytopenia induced by Jui, a traditional Chinese herbal medicine. Lancet 1999; 354: 304-305.
12. Arnold J, Ouwehand WH, Smith G, Cohen H. A young women with petechiae. Lancet 1998; 352: 618.
13. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77: 31-33.
14. Cheng Y, Wong RSM,, Soo YOY, Chui CH, Lau FY, Chan NPH et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003; 349: 831-836.
15. Apostolidis J, Tsandekidi M, Kousiafes D, Pagoni M, Mitsouli C, Karmiris T et al. Short-course corticosteroid-induced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura. Blood 2001; 98: 2875-2877.
16. George JN, Raskob GE, Vesely SK, Moore D, Lyons RM, Cobos E et al. Initial management of immune thrombocytopenic putpura in adults: a randomized controlled trial comparing intermittant anti-D with routine care. Am J Hematol 2003; 74: 161-169.
17. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with idiopathic thrombocytopenic purpura after failure of splenectomy. A systematic review. Ann Int Med 2004; 140: 112-120.
18. Provan D, Newland A. Fifty years of idiopathic thrombocytopenic purpura (ITP): Management of refractory ITP in adults. Br J Haematol 2002; 118: 933-944.
19. Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenia purpura. Blood 2002; 100: 728-730.
20. Bussel JB, George JN, Kuter DJ, Wasser JS, Aledort LM, Chen M-G et al. An open-label, dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG 531) in thrombocytopenic adult patients with immune thrombocytopenic purpura. Blood 2003; 102: 86a.